Acs Dobfar Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ACS DOBFAR, and what generic and branded alternatives to ACS DOBFAR drugs are available?
ACS DOBFAR has twenty-three approved drugs.
Drugs and US Patents for Acs Dobfar
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acs Dobfar | CEFOXITIN | cefoxitin sodium | INJECTABLE;INJECTION | 065415-001 | May 19, 2010 | AP | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Acs Dobfar Spa | AMPICILLIN SODIUM | ampicillin sodium | INJECTABLE;INJECTION | 090884-002 | Apr 3, 2013 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Acs Dobfar Spa | MEROPENEM | meropenem | INJECTABLE;INJECTION | 204139-002 | Jun 9, 2016 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.